Harbor Asset Planning’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Harbor Asset Planning's PFE Position: Q2 2026 in Review
Harbor Asset Planning held its Pfizer (PFE) position steady in Q2 2026 at 850 shares worth $20.5K. The position accounts for 0.02% of the portfolio, ranked #305.
Harbor Asset Planning first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $30K in Q3 2025. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Harbor Asset Planning held 850 shares of Pfizer worth $20.5K as of Q2 2026.
- Harbor Asset Planning left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.02% of Harbor Asset Planning's portfolio in Q2 2026, its #305 holding.
- Harbor Asset Planning first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
- Harbor Asset Planning's Pfizer position peaked at $30K in Q3 2025.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Harbor Asset Planning's 13F filing for Q2 2026, filed 22 Jul 2026.